期刊文献+

HPLC测定S-西酞普兰 被引量:7

Content determination of S-citalopram by chiral high-performance liquid chromatography
暂未订购
导出
摘要 目的拆分西酞普兰(R,S-citalopram)对映异构体,建立S-西酞普兰的质量检测方法.方法采用CHIROBIOTIC V手性柱,以甲醇-冰醋酸一三乙胺(100:0.1:0.1)为流动相,检测波长240nm,柱温20℃,流速1.0min/ml.结果 S、R型异构体获得完全分离,S-西酞普兰在10~150μg/m1范围内具有良好线性,(r=0.999 1,n=5).结论该方法简便、准确,可作为S-西酞普兰含量测定及其R型异构体的含量监控方法. Objective To separate the enantiomers of citalopram and determine the content of S-citalopram using chiral high-performance liquid chromatography (HPLC). Methods The chiral column CHIROBIOTIC V was used with the mobile phase using methanol-acetic acid-triethylamine (100∶0.1∶0.1) at the detection wavelength of 240 nm, column temperature of 20 ℃and flow rate of 1.0 ml/min. Results Complete separation of the enantiomers of citalopram was achieved, and S-citalopram exhibited good linearity within the concentration range of 10 to 150 μg/ml (r=0.9991, n=5). Conclusion This method allows accurate quantification of S- and R-citalopram and is well suited for drug interaction investigations.
出处 《第一军医大学学报》 CSCD 北大核心 2004年第6期716-717,共2页 Journal of First Military Medical University
关键词 手性拆分 S一西酞谱兰 高效液相色谱法 抗抑郁症药物 enantiomer separation S-citalopram high-performance liquid chromatography
  • 相关文献

参考文献7

  • 1Masilamani S,Ruppelt SC.Escitalopram (Lexapro) for depression[J].Am Fam Physician,2003,68(1 1):2235-6.
  • 2Croom KF,Plosker GL.Escitalopram:a pharmacoeconomic review of its use in depression[J].Pharmacoeconomics,2003,21 (16):1185-209.
  • 3Lepola UM,Loft H,Reines EH.Escitalopram (10-20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care[J].Int Clin Psychopharmacol,2003,18(4):211-7.
  • 4Svensson S,Mansfield PR.Escitalopram:superior to citalopram or a chiral chimera[J]? Psychother Psychosom,2004,73(1):10-6.
  • 5Hyttel J,Bogeso KP,PerregaardJ,et al.The pharmacological effect of citalopram residues in the (S)-(+)-enantiomer [J].JNeural Trans (Gen Sect),1992,88(2):157-60.
  • 6Kosel M,Eap CB,Amey M,et al.Analysis of the enantiomers of citalopram and its demethylated metabolites using chiral liquid chromatography[J].JChromatogr B Biomed Sci Appl,1998,719(1-2):234-8.
  • 7郑志昌,UlrichKlotz.西酞普兰及其代谢物的对映体稳态血药浓度[J].贵阳医学院学报,2000,25(3):238-240. 被引量:14

二级参考文献5

  • 1[1]Milne R J, Goa KL. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in depressive illness. Drugs, 1991, 41: 450-446
  • 2[2]Baumann P, Larsen F. The pharmacokinetics of citalopram. Rev Contemp Pharmacother, 1995, 6:287-95
  • 3[3]Hyttel J, Bogeso KP, Perregaad J, et al. The pharmacological effect of citalopram residues in the (S)-(+)-enantiomers. J Neural Transm GenSect, 1992, 88:157-160
  • 4[4]Rochat R. Amey M, Baumann P. Analysis of enantiomers of citalopram and its demethylated metaholites in plasma of depressive patients using chiral reverse phase liquid chromatograhpy. Therapeutic Drug Monitoting , 1995, 17:273-279
  • 5[5]Bertilson L. Geographical/Interracial differences in polymorphic drug oxidation-Current state of knowledge of cytochromes P450 (CYP) 2D6 and 2C19. Clin Pharmacokinet, 1995, 29:192-209

共引文献13

同被引文献32

引证文献7

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部